GlassScriptPhysician profile
Bruce A Silverman
NPI 1912998048
$962.71
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $229 · 2021: $301.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $789.52 | 2019-2021 | |
| Olympus America INC. | $58.93 | 2020-2021 | |
| Abbvie INC. | $42.24 | 2020 | |
| Gilead Sciences, INC. | $24.87 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $19.72 | 2019 | |
| Pfizer INC. | $15.79 | 2019 | |
| Intercept Pharmaceuticals, INC. | $11.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Silverman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.